AACOCF3 (Arachidonyl trifluoromethyl ketone), Phospholipase-A2 inhibitor

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FAAH1 JMJD7-PLA2G4B involves the enzyme fatty acid amide hydrolase 1 (FAAH1) and a fusion protein of the JMJD7-PLA2G4B gene. FAAH1 with a mass of approximately 63 kDa breaks down fatty acid amides such as anandamide. Known as a phospholipase A2 inhibitor FAAH1 is distributed in the brain and liver affecting neurotransmitter regulation and degradation. The enzyme targets specific pathways through substrates like arachidonyl trifluoromethyl ketone (AACOCF3) a known inhibitor of FAAH1 activity indicating its regulatory roles in intracellular signaling.

Biological function summary

FAAH1 serves as a vital component within the endocannabinoid system affecting lipid signaling pathways and neurotransmitter control. It is not usually found in a multi-protein complex functioning largely as a solitary enzyme in its regulatory processes. By controlling endocannabinoid levels FAAH1 modulates synaptic plasticity pain sensation and inflammation having broad impacts on various physiological processes and adaptations.

Pathways

FAAH1 plays a critical role in the endocannabinoid and phospholipid metabolic pathways. The enzyme modulates levels of N-acylethanolamines impacting signal transduction and neuromodulation. It relates to proteins like NAPE-PLD in these pathways which also participate in regulating amide classes and transmission of signals. FAAH1 is essential for maintaining balance within these pathways by regulating bioactive lipid concentrations.

FAAH1 relates to neuropathic pain and inflammatory diseases. The enzyme's regulatory activity on endogenous cannabinoids reveals its potential role in pain management disorders and neural dysfunctions. It connects with proteins such as COX-2 which also plays significant roles in inflammation and pain response. Manipulating FAAH1 activity with inhibitors links to therapeutic strategies for conditions like anxiety and inflammation-related disorders making it a target of interest for new drug development.